Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 8Lymphoid 7Myeloid 5Plasma cell 3Other neoplasm 2

Conditions

Multiple Myeloma 83Neoplasms, Plasma Cell 54Leukemia 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Lymphoma 45Hodgkin Disease 45Myelodysplastic Syndromes 44Lymphoma, Non-Hodgkin 43Leukemia, Myeloid, Acute 43Leukemia, Lymphocytic, Chronic, B-Cell 43Lymphoma, Follicular 35Lymphoma, Large B-Cell, Diffuse 34Lymphoma, Mantle-Cell 32Lymphoma, B-Cell, Marginal Zone 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic-Phase 30Congenital Abnormalities 30Burkitt Lymphoma 30Primary Myelofibrosis 27Myeloproliferative Disorders 27Leukemia, Myeloid, Accelerated Phase 27Leukemia, Myelomonocytic, Chronic 24Blast Crisis 24Recurrence 21Lymphoma, T-Cell, Cutaneous 18Dendritic Cell Sarcoma, Interdigitating 18Waldenstrom Macroglobulinemia 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17Myelodysplastic-Myeloproliferative Diseases 16Pdgfra-Associated Chronic Eosinophilic Leukemia 14

Interventions

Lenalidomide 11Dexamethasone 11fludarabine 9Cyclophosphamide 7Bortezomib 6fludarabine phosphate 5Melphalan 5pomalidomide 4isatuximab 3daratumumab 3Tacrolimus 3Mycophenolic Acid 3Busulfan 3dacetuzumab 2Whole-Body Irradiation 2Thiotepa 2Stem Cell Transplantation 2Leukapheresis 2KW-2478 2Granulocyte Colony-Stimulating Factor 2Cyclosporine 2Calcium Dobesilate 2tanespimycin 1spartalizumab 1sargramostim 1ricolinostat 1pirtobrutinib 1pembrolizumab 1nirogacestat 1ixazomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hematologic Diseases × Busulfan × Plasma cell × Clear all
NCT02660281 2021-11-03

HaploOnly

University of Rochester

Phase 1 Completed
74 enrolled
LymphoidMyeloidPlasma cell

Hematologic Diseases, Lymphoma, Multiple Myeloma, Primary Myelofibrosis

NCT00800839 2016-09-19

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
56 enrolled 10 charts
LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡